RVP Quote, Financials, Valuation and Earnings

Picard Medical has a net margin of 3.68% compared to Retractable Technologies, Inc.'s net margin of --. Retractable Technologies, Inc.'s return on equity of -8.05% beat Picard Medical's return on equity of --.

Retractable Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Picard Medical has an analysts' consensus of -- which suggests that it could fall by --. Given that Retractable Technologies, Inc. has higher upside potential than Picard Medical, analysts believe Retractable Technologies, Inc. is more attractive than Picard Medical.

Retractable Technologies, Inc. has a beta of 1.133, which suggesting that the stock is 13.309% more volatile than S&P 500. In comparison Picard Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Retractable Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Picard Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Retractable Technologies, Inc. pays 1.94% of its earnings as a dividend. Picard Medical pays out -- of its earnings as a dividend. Retractable Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Retractable Technologies, Inc. quarterly revenues are $10.1M, which are larger than Picard Medical quarterly revenues of --. Retractable Technologies, Inc.'s net income of $371K is higher than Picard Medical's net income of --. Notably, Retractable Technologies, Inc.'s price-to-earnings ratio is -- while Picard Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Retractable Technologies, Inc. is 0.64x versus -- for Picard Medical. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of 3.68% compared to Retractable Technologies, Inc.'s net margin of -862.39%. Retractable Technologies, Inc.'s return on equity of -8.05% beat VolitionRX Ltd.'s return on equity of --.

Retractable Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.60 which suggests that it could grow by 734.94%. Given that VolitionRX Ltd. has higher upside potential than Retractable Technologies, Inc., analysts believe VolitionRX Ltd. is more attractive than Retractable Technologies, Inc..

Retractable Technologies, Inc. has a beta of 1.133, which suggesting that the stock is 13.309% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.

Retractable Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Retractable Technologies, Inc. pays 1.94% of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend. Retractable Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Retractable Technologies, Inc. quarterly revenues are $10.1M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Retractable Technologies, Inc.'s net income of $371K is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Retractable Technologies, Inc.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Retractable Technologies, Inc. is 0.64x versus 21.34x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision, Inc. has a net margin of 3.68% compared to Retractable Technologies, Inc.'s net margin of -1037.17%. Retractable Technologies, Inc.'s return on equity of -8.05% beat Catheter Precision, Inc.'s return on equity of -192.05%.

Retractable Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1470.3%. Given that Catheter Precision, Inc. has higher upside potential than Retractable Technologies, Inc., analysts believe Catheter Precision, Inc. is more attractive than Retractable Technologies, Inc..

Retractable Technologies, Inc. has a beta of 1.133, which suggesting that the stock is 13.309% more volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.

Retractable Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Retractable Technologies, Inc. pays 1.94% of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend. Retractable Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Retractable Technologies, Inc. quarterly revenues are $10.1M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Retractable Technologies, Inc.'s net income of $371K is higher than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Retractable Technologies, Inc.'s price-to-earnings ratio is -- while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Retractable Technologies, Inc. is 0.64x versus 11.38x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of 3.68% compared to Retractable Technologies, Inc.'s net margin of 3.93%. Retractable Technologies, Inc.'s return on equity of -8.05% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

Retractable Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 145.78%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Retractable Technologies, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than Retractable Technologies, Inc..

Retractable Technologies, Inc. has a beta of 1.133, which suggesting that the stock is 13.309% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

Retractable Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Retractable Technologies, Inc. pays 1.94% of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend. Retractable Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Retractable Technologies, Inc. quarterly revenues are $10.1M, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Retractable Technologies, Inc.'s net income of $371K is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Retractable Technologies, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 59.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Retractable Technologies, Inc. is 0.64x versus 0.67x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.